Primary outcome analysis: hospital admission with rhabdomyolysis
| Exposure | Unweighted | Weighted | ||
|---|---|---|---|---|
| Events, no. (%) | OR (95% CI) | Events,* no. (%) | OR (95% CI) | |
| Donepezil | 88/152 300 (0.06) | 2.46 (1.44–4.19) | 88/152 300 (0.06) | 2.21 (1.52–3.22) |
| Rivastigmine or galantamine | 16/68 053 (0.02) | Referent | 39.78/152 161 (0.03) | Referent |
Note: CI = confidence interval, OR = odds ratio.
↵* Weighted events are not true event rates in the rivastigmine or galantamine group, but frequencies based on weighted analysis.